Study of Pembrolizumab With Chemotherapy in Patients With Advanced Lymphoma (PembroHeme)

NCT02408042 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Lymphoma
Hodgkin's Lymphoma
Non-hodgkin's Lymphoma

Interventions

DRUG: Pembrolizumab
DRUG: Etoposide
DRUG: Ifosfamide
DRUG: Mesna
DRUG: Carboplatin
DRUG: Brentuximab vedotin
DRUG: Rituximab

Sponsor

Western Regional Medical Center